Inventor · disambiguated record
David Norman Deaton
Also filed as: DEATON DAVID N · DEATON DAVID NORMAN
14 granted patents·8 pending applications·135 citations·filing 1997–2019
91Inventor score
Files withSMITHKLINE BEECHAM CORP8GLAXOSMITHKLINE IP DEV LTD5GLAXO WELLCOME INC2GLAXOSMITHKLINE LLC2CALDWELL RICHARD1
Top patents by PatentIndex Score
22 records- 0184US8158665B2Farnesoid X receptor agonistsCALDWELL RICHARD·Filed 2010·Granted Apr 17, 2012·12 cites·15 claims
- 0283US7034053B2Phenethanolamine derivatives, compositions, and their use as agonists at atypical beta-adrenoreceptorsSMITHKLINE BEECHAM CORP·Filed 2001·Granted Apr 25, 2006·11 cites·11 claims
- 0380US7705028B2Farnesoid X receptor agonistsGLAXOSMITHKLINE LLC·Filed 2006·Granted Apr 27, 2010·6 cites·18 claims
- 0479US7196201B2Pyrrolidines as dipeptidyl peptidase inhibitorsSMITHKLINE BEECHAM CORP·Filed 2002·Granted Mar 27, 2007·14 cites·1 claims
- 0576US6294580B1Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gammaGLAXO WELLCOME INC·Filed 1997·Granted Sep 25, 2001·48 cites·33 claims
- 0674US7960552B2Farnesoid X receptor agonistsGLAXOSMITHKLINE LLC·Filed 2007·Granted Jun 14, 2011·3 cites·6 claims
- 0769US6455507B1Benzimidazole derivativesSMITHKLINE BEECHAM CORP·Filed 1998·Granted Sep 24, 2002·27 cites·29 claims
- 0866US6172064B1Formamides as therapeutic agentsGLAXO WELLCOME INC·Filed 1999·Granted Jan 9, 2001·12 cites·21 claims
- 0963US9840496B2CD38 inhibitors and methods of treatmentGLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD·Filed 2015·Granted Dec 12, 2017·1 cites·6 claims
- 1061US7282512B2Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitorsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Oct 16, 2007·1 cites·33 claims
- 1155US2006148887A1Chemical compoundsDEATON DAVID N·Filed 2006·Application pending·0 cites
- 1254US11053234B21,3 di-substituted cyclobutane or azetidine derivatives as hematopoietic prostaglandin D synthase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Jul 6, 2021·0 cites·12 claims
- 1353US2008058333A1Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitorsCATALANO JOHN G·Filed 2007·Application pending·0 cites
- 1448US2010249179A1Farnesoid X Receptor AgonistsSMITHKLINE BEECHAM CORP·Filed 2008·Application pending·0 cites
- 1544US2021139507A1Fused pyridines which act as inhibitors of h pgdsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Application pending·0 cites
- 1643US11149035B2Chemical compounds as H—PGDS inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Oct 19, 2021·0 cites·16 claims
- 1743US2022009918A1Chemical CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Application pending·0 cites
- 1842US7402606B2Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone lossSMITHKLINE BEECHAM CORP·Filed 2003·Granted Jul 22, 2008·0 cites·46 claims
- 1942US2011034507A1Farnesoid x receptor agonistsSMITHKLINE BEECHAM CORP·Filed 2008·Application pending·0 cites
- 2039US7288541B2Propylcarbamate derivatives as inhibitors of serine and cysteine proteasesSMITHKLINE BEECHAM CORP·Filed 2002·Granted Oct 30, 2007·0 cites·33 claims
- 2137US2005107616A1Alpha-ketoamide derivatives as cathepsin k inhibitorsFiled 2002·Application pending·0 cites
- 2236US2021238162A1Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Norman Deaton files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →